Form 4: Century Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Douglas Carr, SVP Finance & Operations of Century Therapeutics, Inc., sold 254 shares of common stock on September 8, 2026 for $2.05 per share.
Summary
- Open-market sale: disposed of 254 Common Stock at $2.05 ($521) on September 8, 2026; holds 504,565 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $521 of stock on the open market.
Insider Transactions
Douglas Carr — Officer (SVP Finance & Operations)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | Common Stock | 254 | $2 | $521 | 504,565 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (254 shares) |
Keywords
insider transaction, Form 4, IPSC, Century Therapeutics, Inc., bearish, Douglas Carr
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.